• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of Gene Imaging Technique Using Radiolabeled Antisense DNA

Research Project

Project/Area Number 08457241
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionKanazawa University

Principal Investigator

TONAMI Norihisa  Kanazawa University School of Medicine, Professor, 医学部, 教授 (60019940)

Co-Investigator(Kenkyū-buntansha) SHIBA Kazuhiro  Kanazawa University Radioisotope Center, Assistant, アイソトープ総合センター, 助手 (40143929)
YOKOYAMA Kunihiko  Kanazawa University Hospital, Lecturer, 医学部・附属病院, 講師 (60230661)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥5,600,000 (Direct Cost: ¥5,600,000)
Fiscal Year 1997: ¥1,800,000 (Direct Cost: ¥1,800,000)
Fiscal Year 1996: ¥3,800,000 (Direct Cost: ¥3,800,000)
Keywordsantisense DNA / oligonucleotide / radioisotope / imaging diagnosis / gene imaging / delivery system / induced hypertension / オリゴヌクレオテド / デリバリィ システム
Research Abstract

Using radiolabeled antisense oligonucletides(DNA), lesions of amplified mRNA can be imaged with gamma cameras. For this approach, the stable radiometal chelates, which are appropriate for oligonucletide, is required. We have developed the in vivo model system where nude mice xenografted tumor cells express P-glycoprotein (P-gp). To image multidrug resistant tumors caused by P-gp, we designed the 15mer of antisense DNA sequence for the mdrl gene coding P-gp. The 5'-end of the oligonucletide was modified with the thiol group and the maleimido-C3-benzyl-EDTA chelate was reacted. However, the final product was not identified as the objective compound. Further investigation was warranted. The small molecules like oligonucleotides tend to be cleared very rapidly from the blood and therefore, the absolute tumor uptake of this kind of the tracer is limited. We have tried to increase the tumor uptake of radiolabeled antibodies by modifying the hemodynamics of the tumor tissue. The combination usage of angiotensin-Il, continuously infused at 2 mug/kg/min, and a kininase inhibitor, enalapril maleate, 30 jig increased the mouse blood pressure from 95/61 to 153/67. And the tumor uptake was also increased by the factor of 1.62 with little change in normal organ distribution. The autoradiography showed that more homogeneous distribution of the radiolabeled antibody in the tumor because of recanalization of vascular beds and increased vascular permeability. In conclusions, enhanced tumor uptake was achieved by manipulating hemodynamics and vascular permeability of the tumor tissue and this technique can be applied for smaller molecule as the oligonucleotides.

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi